Campestrini J

References (3)

Title : Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects - He_2008_J.Clin.Pharmacol_48_85
Author(s) : He YL , Ligueros-Saylan M , Sunkara G , Sabo R , Zhao C , Wang Y , Campestrini J , Pommier F , Dole K , Marion A , Dole WP , Howard D
Ref : Journal of Clinical Pharmacology , 48 :85 , 2008
Abstract :
PubMedSearch : He_2008_J.Clin.Pharmacol_48_85
PubMedID: 17986525

Title : Dose proportionality and the effect of food on vildagliptin, a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers - Sunkara_2007_J.Clin.Pharmacol_47_1152
Author(s) : Sunkara G , Sabo R , Wang Y , He YL , Campestrini J , Rosenberg M , Howard D , Dole WP
Ref : Journal of Clinical Pharmacology , 47 :1152 , 2007
Abstract :
PubMedSearch : Sunkara_2007_J.Clin.Pharmacol_47_1152
PubMedID: 17656620

Title : The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin - He_2007_Eur.J.Clin.Pharmacol_63_677
Author(s) : He YL , Sabo R , Campestrini J , Wang Y , Ligueros-Saylan M , Lasseter KC , Dilzer SC , Howard D , Dole WP
Ref : European Journal of Clinical Pharmacology , 63 :677 , 2007
Abstract :
PubMedSearch : He_2007_Eur.J.Clin.Pharmacol_63_677
PubMedID: 17486328